Pilot Study of an Online Therapeutic Education Program for Patients With Inflammatory Bowel Disease (EDUMICILOR)

Central Hospital, Nancy, France

Status: Unknown

Conditions: Ulcerative Colitis; Crohn's Disease

Treatments: Other: EDUMICILOR

Study type: Interventional

Funder types: Other

Identifiers

NCT03648398

APPARA2018/EDUMICILOR-VELTIN

Details and patient eligibility

About

EDUMICILOR is a monocentric prospective pilot study for patients with inflammatory bowel disease (IBD).

During the study, patients will participate in an online therapeutic education program.

They will first have an appointment with a nurse to establish a personalized educational diagnosis. Then they will participate in the online therapeutic education program for about 6 months (depends on the educational needs, expectations and patient's availabilities).

The main objective of this study is to assess the feasibility of an online therapeutic education program for IBD patients.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female (age ≥ 18 years old)
• Patients with established Crohn's disease or ulcerative colitis diagnosis
• Patients who own the equipment to participate in the online therapeutic education program (computer, webcam....)
• French speaking patients
• Patients who cannot attend regular therapeutic education sessions at the hospital
• Patients able to understand the information provided to them and to give written informed consent for the study

Exclusion criteria

• Patient who has not given his/her consent to participate

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

EDUMICILOR

Other group

Description:

Patients will participate in the online therapeutic education program for about 6 months

Treatment:

Other: EDUMICILOR